← SynDRA
Gne-7915
SynDRA canonical compound SYN0057641 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LRRK2 |
|---|
| Mechanism of action | leucine rich repeat kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- LRRK2 BINDER
- LRRK2 INHIBITOR
- TTK INHIBITOR
- leucine rich repeat kinase inhibitor
Cross-references
Synonyms
- GNE7915
- GNE 7915
- RefChem:144065
- MFCD25977005
- C19H21F4N5O3
- A0T
- GTPL8073
- orb1307020
- SCHEMBL7456100
- SCHEMBL29597033
- XCFLWTZSJYBCPF-UHFFFAOYSA-N
- GLXC-90050
- HMS3653J13
- HMS3674E09
- EX-A1001
- IJD48701
- BDBM50398668
- GNE-7915?
- s7528
- AKOS026750276
- CCG-269162
- EBC-220118
- SB19411
- NCGC00386346-05
- AC-35918
- AS-17060
- DA-33601
- HY-18163
- SY294194
- G5216
- SW219477-1
- T1945
- US8802674, 256
Look up Gne-7915 in the interactive SynDRA portal →